Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis

Vaccine

Volumn 30, Issue 15, 2012, Pages 2600-2604

  Leder, K ^a,b   Chen, L H ^c,e   Wilson, M E ^d  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MOUNT AUBURN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cumulative risks; Pre travel vaccines; Travellers

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; MENINGOCOCCUS VACCINE; RABIES VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ARTICLE; HEPATITIS A; HEPATITIS B; HUMAN; MENINGOCOCCOSIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RABIES; RISK ASSESSMENT; TRAVEL; TYPHOID FEVER; VACCINATION; WORLD HEALTH ORGANIZATION; YELLOW FEVER;

COMMUNICABLE DISEASE CONTROL; HUMANS; RISK ASSESSMENT; TRAVEL; VACCINATION; VACCINES;

EID: 84862783307     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.133     Document Type: Article

References (44)

1. WHO International Travel and Health: the Green book; 2012.
2. CDC Health Information for International travel: the Yellow book; 2012.
3. Nielsen U.S., Petersen E., Larsen C.S. Hepatitis B immunization coverage and risk behaviour among Danish travellers: are immunization strategies based on single journey itineraries rational?. J Infect 2009, 59(November (5)):353-359.
4. US Department of Commerce ITA Tourism Industries. Profile of U.S. Resident Travelers Visiting Overseas Destinations: 2009 outbound. Reported From: Survey of International Air Travelers. US Department of Commerce ITA Tourism Industries. Accessed June 2011 [cited; available from: ]. http://tinet.ita.doc.gov/outreachpages/download_data_table/2009_Outbound_Profile.pdfhttp%3A//tinet.ita.doc.gov/.
5. Angell S.Y., Cetron M.S. Health disparities among travelers visiting friends and relatives abroad. Ann Intern Med 2005, 142(January (1)):67-72.
6. Bacaner N., Stauffer B., Boulware D.R., Walker P.F., Keystone J.S. Travel medicine considerations for North American immigrants visiting friends and relatives. J Am Med Assoc 2004, 291(June (23)):2856-2864.
7. Leder K., Tong S., Weld L., Kain K.C., Wilder-Smith A., von Sonnenburg F., et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2006, 43(November (9)):1185-1193.
8. Fisman D.N., Agrawal D., Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002, 35(December (11)):1368-1375.
9. Genton B., D'Acremont V., Furrer H.J., Hatz C., Louis L. Hepatitis A vaccines and the elderly. Travel Med Infect Dis 2006, 4(December (6)):303-312.
10. Khromava A.Y., Eidex R.B., Weld L.H., Kohl K.S., Bradshaw R.D., Chen R.T., et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 2005, 23(May (25)):3256-3263.
11. Gautret P., Shaw M., Gazin P., Soula G., Delmont J., Parola P., et al. Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. J Travel Med 2008, 15(January-February (1)):25-30.
12. Shaw M.T., O'Brien B., Leggat P.A. Rabies postexposure management of travelers presenting to travel health clinics in Auckland and Hamilton, New Zealand. J Travel Med 2009, 16(January-February (1)):13-17.
13. Altmann M., Parola P., Delmont J., Brouqui P., Gautret P. Knowledge, attitudes, and practices of French travelers from Marseille regarding rabies risk and prevention. J Travel Med 2009, 16(March-April (2)):107-111.
14. Piyaphanee W., Shantavasinkul P., Phumratanaprapin W., Udomchaisakul P., Wichianprasat P., Benjavongkulchai M., et al. Rabies exposure risk among foreign backpackers in Southeast Asia. Am J Trop Med Hyg 2010, 82(June (6)):1168-1171.
15. Gautret P., Schwartz E., Shaw M., Soula G., Gazin P., Delmont J., et al. Animal-associated injuries and related diseases among returned travellers: a review of the GeoSentinel Surveillance Network. Vaccine 2007, 25(March (14)):2656-2663.
16. Bernard K.W., Fishbein D.B. Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?. Vaccine 1991, 9(November (11)):833-836.
17. Shantavasinkul P., Tantawichien T., Wacharapluesadee S., Jeamanukoolkit A., Udomchaisakul P., Chattranukulchai P., et al. Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations. Clin Infect Dis 2010, 50(January (1)):77-79.
18. Shantavasinkul P., Tantawichien T., Wilde H., Sawangvaree A., Kumchat A., Ruksaket N., et al. Postexposure rabies prophylaxis completed in 1 week: preliminary study. Clin Infect Dis 2010, 50(January (1)):56-60.
19. Van Damme P., Banatvala J., Fay O., Iwarson S., McMahon B., Van Herck K., et al. Hepatitis A booster vaccination: is there a need?. Lancet 2003, 362(September (9389)):1065-1071.
20. McMahon B.J., Dentinger C.M., Bruden D., Zanis C., Peters H., Hurlburt D., et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009, 200(November (9)):1390-1396.
21. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II. Immunization of adults. MMWR Recomm Rep 2006;55(December (RR-16)):1-33; quiz CE1-4.
22. CDC Travelers' Health Yellow Book, Chapter 3: hepatitis B [cited; available from: ]. http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/hepatitis-b.htm.
23. World Health Organisation (Green Book): International travel and health. Chapter 6: vaccine-preventable diseases and vaccines; 2011 [cited; available from: ]. http://www.who.int/ith/chapters/ith2011chap6.pdf.
24. Chen LH BE, Wilson ME, MacLeod WB, Yanni E, Karchmer AW, Ooi WW, et al. Hepatitis B status in travellers seen in the Boston Area Travel Medicine Network (BATMN). In: Abstracts for the 7th European congress on tropical medicine and international health; 2011.
25. CDC Travelers' Health Yellow Book, Chapter 3: Yellow fever [cited; available from: ]. http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/yellow-fever.htm.
26. Rossi I, Genton, B. The reliability of pre-travel history to decide on appropriate counselling and vaccinations: a prospective study. In: Abstracts from the 12th conference of the international society of travel medicine, FC02.04.
27. Monath T.P., Fowler E., Johnson C.T., Balser J., Morin M.J., Sisti M., et al. An inactivated cell-culture vaccine against yellow fever. N Engl J Med 2011, 364(April (14)):1326-1333.
28. CDC Travelers' Health Yellow Book, Chapter 3: Japanese encephalitis [cited; available from: ]. http://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/japanese-encephalitis.htm.
29. Wilder-Smith A., Halstead S. Japanese encephalitis: update on vaccines and vaccine recommendations. Curr Opin Infect Dis 2010, 23(5):426-431.
30. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine - advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2011;60(May (20)):661-3.
31. Nasveld P.E., Ebringer A., Elmes N., Bennett S., Yoksan S., Aaskov J., et al. Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine: randomized, double-blind, 5-year phase II study in healthy adults. Hum Vaccin 2010, 6(December (12)):1038-1046.
32. Updated recommendations for use of meningococcal conjugate vaccines - Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;60(January (3)):72-6.
33. Typhoid Immunization Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1994;43(December (14)):1-7.
34. Mutsch M., Spicher, Gut V., Steffen C., Hepatitis R. A virus infections in travelers, 1988-2004. Clin Infect Dis 2006, 42:490-497.
35. Sonder G.J., van Rijckevorsel G.G., van den Hoek A. Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?. J Travel Med 2009, 16(January-February (1)):18-22.
36. Steffen R. Risks of hepatitis B for travellers. Vaccine 1990;(March (8 Suppl)):S31-2; discussion S41-3.
37. Hatz C., Werlein J., Mutsch M., Hufnagel M., Behrens R.H. Japanese encephalitis: defining risk incidence for travelers to endemic countries and vaccine prescribing from the UK and Switzerland. J Travel Med 2009, 16(May-June (3)):200-203.
38. Shlim D.R., Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002, 35(2):183-188.
39. Koch S., Steffen R. Meningococcal disease in travelers: vaccination recommendations. J Travel Med 1994, 1(March (1)):4-7.
40. Pandey P., Shlim D.R., Cave W., Springer M.F. Risk of possible exposure to rabies among tourists and foreign residents in Nepal. J Travel Med 2002, 9(May-June (3)):127-131.
41. Gautret P., Parola P. Rabies vaccination for international travelers. Vaccine 2012, 30(2):126-133.
42. Lynch M.F., Blanton E.M., Bulens S., Polyak C., Vojdani J., Stevenson J., et al. Typhoid fever in the United States, 1999-2006. J Am Med Assoc 2009, 302(August (8)):859-865.
43. Keller A., Frey M., Schmid H., Steffen R., Walker T., Schlagenhauf P. Imported typhoid fever in Switzerland, 1993 to 2004. J Travel Med 2008, 15(July-August (4)):248-251.
44. Monath T.P., Cetron M.S. Prevention of yellow fever in persons traveling to the tropics. Clin Infect Dis 2002, 34(10):1369-1378. [erratum appears in Clin Infect Dis 2002;35(July (1)):110].